Prostatic Artery Embolization is Now Being Used to Treat Benign Prostatic Hyperplasia

Prostatic artery embolization (PAE) is a relatively recent advancement in surgical treatment for patients with benign prostatic hyperplasia (BPH). BPH is caused by an enlarging of the prostate and is very common among middle-aged and older men, affecting approximately 50 percent of men in their 50s and as many as 90 percent of men in their 80s. Many men will only experience moderate BPH, which can result in a variety of unpleasant symptoms, such as frequent urination or difficulty starting to urinate. However, in severe cases, the urinary tract may become blocked, causing more serious problems such as urinary tract infections and kidney problems.

For men dealing with BPH, there are a number of treatment options available, including medications that may help relieve symptoms or shrink the prostate. However, for men with severe cases of BPH, for those who do not find relief with medication, and for those with a significantly enlarged prostate or a prostate size that is considered higher risk for transurethral resection of the prostate (TURP), prostatic arterial embolization may be a viable treatment option. PAE is a minimally invasive procedure that involves guiding a catheter through the radial artery (located in the wrist) to reach blood vessels that supply blood to the prostate. These blood vessels are then selectively blocked, thereby causing the prostate to shrink over time and relieving pressure on the urethra.

Tampa General Hospital is among the pioneering hospitals in the PAE surgical procedure. Our multidisciplinary team, including surgeons, physicians, and other specialists, is committed to utilizing the latest advancements in diagnostic and treatment technologies to provide the best possible outcomes for our patients.

To begin the evaluation process for prostatic artery embolization at Tampa General Hospital, submit an online form or contact our PAE program coordinator by calling (813) 844-5072.